抑制性PD-1軸は,幹細胞のようなCD8+ T細胞を保持する
Jyh Liang Hor1, Edward C Schrom2, Abigail Wong-Rolle2,3
1Lymphocyte Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA. jyhliang.hor@nih.gov.
Nature
|November 26, 2025
まとめ
チェックポイント免疫療法は 幹細胞のような細胞毒性T細胞に依存しています 持続的なT細胞受容体信号ではなく,長時間続く抗原結合がこれらの細胞を維持し,PD-1は高親和性の拡張を微調整します.
科学分野:
- 免疫学
- 癌 生物学
- T細胞生物学
背景:
- 幹細胞のような細胞毒性T細胞は 効果的ながん免疫療法に不可欠です.
- 腫瘍を排水するリンパ節は これらの幹細胞の生成と維持に不可欠です
- T細胞幹細胞性を促進する要因を理解することは 免疫療法の改善の鍵です
研究 の 目的:
- 幹細胞のようなCD8+T細胞を支える腫瘍排水リンパ節の抗原プレゼンテーションニッチを特定する.
- T細胞受容体 (TCR) 信号伝達とPD-1がT細胞幹性の維持に果たす役割を明らかにする.
- 高親和性T細胞クローンに対するPD-1阻害の影響を調査する.
主な方法:
- 先進的な3次元複合免疫光成像
- T細胞の増殖と分化に関する in vivo 研究
- T細胞受容体 (TCR) 信号ダイナミクスとPD-1経路の機能の分析
主要な成果:
- 幹細胞のようなT細胞の膨張と親近性の進化を支える,腫瘍を排泄するリンパ節の特定のニッチを特定した.
- T細胞の自己再生を 維持していることが示されました
- PD-1経路は TCR信号を調整し 高親和性のクローンの 選択的な拡張を可能にしました
結論:
- 抗原の関与とPD-1のシグナル伝達は,高親和性抗腫瘍T細胞の再生可能なプールを維持するために重要である.
- PD-1の封鎖は,このプロセスを妨害し,重要な幹のような前駆体を失う可能性があります.
- この発見は,T細胞の分化に関する現在の理解に異議を唱え,PD-1抗がん免疫療法戦略の最適化に意味を持つ.
関連する概念動画
T Cell Activation and Clonal Selection
14.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.5K
Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K


